Related Experiment Videos

Macrophage complement and lectin-like receptors bind Leishmania in the absence of serum

Insights

Macrophage receptors CR3 and MFR both bind Leishmania donovani. Blocking either receptor inhibits parasite binding, suggesting a combined mechanism for pathogen recognition and ingestion.

Area of Science:

  • Immunology
  • Cell Biology
  • Parasitology

Background:

  • Leishmania donovani is a protozoan parasite that infects macrophages.
  • Macrophage recognition and ingestion of pathogens involve plasma membrane receptors.

Purpose of the Study:

  • To investigate the roles of macrophage receptors CR3 and MFR in Leishmania donovani binding and ingestion.
  • To determine if these receptors function independently or cooperatively.

Main Methods:

  • Inhibition of CR3 and MFR activity using monoclonal antibodies and soluble inhibitors.
  • Modulation experiments to assess receptor accessibility on macrophage membranes.
  • Assessment of Leishmania donovani promastigote and amastigote binding and ingestion.

Main Results:

  • CR3-mediated binding of Leishmania promastigotes was confirmed by inhibiting C3 fixation.
  • Mannan and ribonuclease B inhibited MFR-mediated binding, showing equivalent effects to CR3 inhibition.
  • No additive effect was observed when blocking both receptors simultaneously.
  • Both CR3 and MFR must be present on the macrophage membrane for parasite binding.

Conclusions:

  • CR3 and MFR play significant, cooperative roles in the recognition and ingestion of Leishmania donovani by macrophages.
  • This dual-receptor mechanism may be a general pathway for macrophage interaction with other protozoan parasites activating the alternative complement pathway.

Related Concept Videos